Optibiotix Health Share Discussion Threads

[trotterstrading] 29/11/2016 08:05

Low blow Scotty I think that's fairly obvious mate, of course they can't guarantee they will lead to contracts. Remember RNS have to go through legal review prior to publishing.

[f3rdinand] 29/11/2016 08:05

5 commercial deals out of 6 will do me fine! :)

[scotty1] 29/11/2016 07:59

Anyone notice

"Whilst OptiBiotix cannot guarantee that all discussions will lead to commercial deals"

[john henry] 29/11/2016 07:57

Anyone notice the word PHARMACEUTICAL appearing .

[sukithedog] 29/11/2016 07:55

How's trackm8 doing??? Lol

[michaelmouse] 29/11/2016 07:54

Weren't they supposed to have announced commercial deals in the Spring, then the Summer, then October, then November, then before Christmas.

Now we have it. NO COMMERCIAL DEALS.

[rafboy] 29/11/2016 07:52

Great news, let's hope we have the deals done soon.

[someuwin] 29/11/2016 07:50

imo the longer the discussions and due dilligence takes, the bigger the eventual deals.

[trotterstrading] 29/11/2016 07:46

Another good scientific update, I think we have all been surprised by how long the big commercial deals have taken to tie down, but if the science is there the rest will follow, but we need to be patient, our rewards will be worth the wait

[someuwin] 29/11/2016 07:42

Share Prophets ‏@ShareProphets 22 minutes ago

Just posted: Optibiotix (#OPTI) says in late stage commercial discussions with SIX ( yes SIX) potential partners

[scotty1] 29/11/2016 07:41

Yep another jam tomorrow (hopefully) rns

[sukithedog] 29/11/2016 07:37

Mouse deramping won't work
Excellent update, may be you can't read

[michaelmouse] 29/11/2016 07:35

At a market cap. of near £50m I'd be interested if we could discuss the numbers on this one. You know revenue, profits, cash flow etc...... LOL.

[michaelmouse] 29/11/2016 07:30

Great RNS this morning! LOL.

If Carlsberg did desperate RNS's then OptiBiotix would be your company.

This mornings RNS tells you absolutely nothing and is a desperate attempt to keep the share price propped up after promising for months significant news. Placing coming up at 30p?

In short no commercial deals.

I love this line, "Whilst OptiBiotix cannot guarantee that all discussions will lead to commercial deals it wants to update shareholders on the ongoing commercial progress being made across all of its products and platforms."

My guess is no deals for months/years. New target 30p.

[loveandmoney1] 29/11/2016 07:30

more flowery puff....


but no deal........

[deeppockets] 29/11/2016 07:20

Jam tomorrow but we can smell it now!!

[someuwin] 29/11/2016 07:07

OptiBiotix Health plc

("OptiBiotix" or the "Company")

Scientific and Commercial Update

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, provides the following scientific and commercial update.

Scientific Update

OptiBiotix has made significant progress in its scientific programmes to develop compounds which modify the human microbiome to prevent, manage and treat disease. The Company believes these developments have the potential to rapidly accelerate the Company's growth. Recent developments include: -

· OptiBiotix's ability to manipulate both the microbiome's composition and its function. This creates the potential for:-

ü Designer ingredients or supplements which can modify an individual's current microbiome to improve health.

ü The potential for precision microbiome medicine. This is an area of growing scientific and commercial interest with growing evidence that the microbiome plays an important role in how the body metabolises pharmaceutical products, influencing their effectiveness and the potential for adverse reactions.

· OptiBiotix has demonstrated the ability of its novel oligosaccharides (carbohydrates that consist of a small number of sugars) to reduce cholesterol in human gut models by >20%. These sugars are heat resistant and stable during processing making them suitable as ingredients in a wide range of products. This finding extends the existing product opportunity offered by OptiBiotix's LP-LDL cholesterol reducing strain from supplements to ingredients, greatly increasing the market opportunity.

The results of these studies have been submitted for publication and presentation in mainstream scientific journals and conferences throughout 2017.

Commercial Update

OptiBiotix reports that it has reached late stage commercial discussions with six commercial partners across its technology and product platforms. A number of these discussions have been ongoing for many months and have involved extensive due diligence of OptiBiotix's science, intellectual property, and the partners assessment of the scale of the market opportunity across international markets. These discussions include a number of leading industry corporate players who provide product development, manufacturing, distribution, and/or routes to global markets.

Whilst OptiBiotix cannot guarantee that all discussions will lead to commercial deals it wants to update shareholders on the ongoing commercial progress being made across all of its products and platforms.

Stephen O'Hara, CEO of OptiBiotix, commented: "The Company believes it is making strong scientific progress across all its technology and product platforms. These research findings add to the growing scientific evidence base of how OptiBiotix's technology influences the microbiome to prevent, manage, and treat disease. This helps convert existing commercial interest into commercial deals and opens up opportunities in new markets. The overall aim being to develop multiple revenue streams from both consumer and pharmaceutical products across all its technology platforms."

[f3rdinand] 29/11/2016 07:06

Patience here will be richly rewarded!

[f3rdinand] 29/11/2016 06:37

SOH yesterday said in his interview...Optibiotix products? If we were going into the launch with a MN then surely it would be their products with our 'ingredients'My gut feeling now is that we are going alone in the spring as numerous big players are interested- but dragging their feet! Us putting products out their will force their hand...maybe even to buy out the cholesterol division if it's a roaring success!We shall see

[belgrano2] 28/11/2016 21:31

at a real good price as well

[elrico] 28/11/2016 19:39

How's that TRAKM8 business model doing, michaelmouse! Hate to say I told you so, but you would wouldn't you. I did say a company that cooks the books by fattening it's numbers by going on an acquisition spree is hiding something. Today's 31% crash may seem a cheap as chips to you and like you did with AVN, you probably think it's worth bottom fishing - you were wrong with AN of course, as they are 55% down from your advisory then. 60p would be my guess to attempt this.

I'm not gloating, I'm just giving you a taste of your own in the hope you learn some humility.

[john henry] 28/11/2016 18:45

Well from 12.30 there was no more sells, so I guess the buyer had hoovered them up.

[parob] 28/11/2016 18:05

So 75k shares bought right at the end of the day. If an II is keen to accumulate at these levels, then you can be fairly confident this is the floor.